Boothbay Fund Management’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-30,570
| Closed | -$312K | – | 1801 |
|
|
2023
Q2 | $312K | Buy |
30,570
+14,167
| +86% | +$144K | 0.01% | 1082 |
|
|
2023
Q1 | $149K | Buy |
16,403
+2,450
| +18% | +$22.2K | ﹤0.01% | 1581 |
|
|
2022
Q4 | $100K | Sell |
13,953
-26,798
| -66% | -$192K | ﹤0.01% | 1544 |
|
|
2022
Q3 | $266K | Sell |
40,751
-44,711
| -52% | -$292K | 0.01% | 1381 |
|
|
2022
Q2 | $412K | Sell |
85,462
-1,173
| -1% | -$5.66K | 0.01% | 1112 |
|
|
2022
Q1 | $492K | Hold |
86,635
| – | – | 0.01% | 1025 |
|
|
2021
Q4 | $435K | Hold |
86,635
| – | – | 0.01% | 936 |
|
|
2021
Q3 | $576K | Sell |
86,635
-38,192
| -31% | -$254K | 0.02% | 836 |
|
|
2021
Q2 | $763K | Sell |
124,827
-9,689
| -7% | -$59.2K | 0.02% | 700 |
|
|
2021
Q1 | $895K | Sell |
134,516
-16,183
| -11% | -$108K | 0.03% | 528 |
|
|
2020
Q4 | $797K | Sell |
150,699
-1,542
| -1% | -$8.16K | 0.03% | 474 |
|
|
2020
Q3 | $1.13M | Buy |
152,241
+30
| +0% | +$223 | 0.07% | 331 |
|
|
2020
Q2 | $1.12M | Buy |
152,211
+36,823
| +32% | +$271K | 0.08% | 291 |
|
|
2020
Q1 | $854K | Buy |
+115,388
| New | +$854K | 0.07% | 291 |
|